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2 	  
Abstract 28	  
Objective: To determine the clinical, radiographic and patient-reported outcomes of a one-29	  
piece alumina-toughened zirconia (ATZ) implant restored with single crowns (SC) or three-30	  
unit fixed dental prostheses (FDP) after three years of observation. 31	  
Materials and Methods: Forty patients received 53 implants, placed in a one-stage surgery 32	  
with immediate temporization. Finally, 50 implants were restored with 24 SCs and 13 FDPs. 33	  
To evaluate peri-implant bone loss, standardized radiographs were taken at implant insertion, 34	  
at final restoration delivery, and after one and three years. Additionally, several soft tissue 35	  
parameters and patient-reported outcome measures (PROMs) were evaluated. Linear mixed 36	  
models with random intercept for each patient and patients as clusters were used to compare 37	  
subgroups. 38	  
Results: Three patients did not receive a SC due to early implant loss and one patient died. As 39	  
a result, 36 patients with 49 implants were followed-up for three years giving a cumulative 40	  
survival rate of 94.2%. The average marginal bone loss amounted to 0.79 mm (SCs: 0.47mm; 41	  
FDPs: 1.07mm; p<0.001). After the delivery of the final prosthetic restoration, further bone 42	  
loss was not statistically significant (0.09mm; p=0.700). Probing depth, clinical attachment 43	  
level and modified bleeding index increased significantly at the implant sites, whereas 44	  
gingival recession decreased significantly. Compared with the pre-treatment questionnaires, 45	  
the PROMs showed a permanently improved perception of function, esthetics, sense, speech 46	  
and self-esteem. 47	  
Conclusion: The survival rate of the investigated ceramic implant system seems to be 48	  
comparable to reported survival rates of titanium implants when immediately restored. The 49	  
recorded parameters suggest its clinical utilization. 50	  
(249/250 words)  51	  
3 	  
Introduction  52	  
Clinical long-term results reported for titanium implants have made titanium the “gold 53	  
standard” material for the fabrication of oral implants (Jung et al. 2012; Pjetursson et al. 54	  
2012). Nevertheless, there are still concerns that titanium might evoke an unwelcome host 55	  
reaction. However, it remains unproven and difficult to certainly diagnose whether titanium is 56	  
causal for allergic reactions in patients with dental or even orthopedic implants of a larger 57	  
dimension (Hallab et al. 2001; Javed et al. 2013). Even so, the rising popularity of metal-free 58	  
reconstructions motivates clinicians to offer implants of alternative materials, e.g. ceramic 59	  
implants made of zirconia. Aside from possibly favorable tissue health considerations, one of 60	  
the main advantages of whitish ceramic implant/abutment materials might be an esthetic 61	  
benefit in the presence of a thin soft tissue biotype (Cosgarea et al. 2015; Jung et al. 2007). 62	  
Especially in the occurrence of buccal hard tissue recession in anterior cases resulting in 63	  
subgingival implant surface exposure, the compensation potential of solely ceramic abutments 64	  
might be limited. Yttria-stabilized zirconia (Yttria-stabilized tetragonal zirconia polycrystal, 65	  
Y-TZP) seems to be the favorable ceramic for the manufacturing of dental implants. The 66	  
material is characterized by a dense, monocrystalline homogeneity. Y-TZP shows a high 67	  
flexural strength and high fracture toughness (Table 1). These characteristics are based on a 68	  
phase transformation toughening mechanism (Christel et al. 1989). Pre-clinical laboratory 69	  
investigations revealed that implants made of Y-TZP may withstand long-term oral chewing 70	  
forces (Andreiotelli and Kohal 2009). In vitro, in vivo and animal experiments proved their 71	  
potential for a successful clinical application (Andreiotelli et al. 2009). Besides Y-TZP, 72	  
another ceramic composite with a modified toughening mechanism (alumina-toughened 73	  
zirconia = ATZ) proved to be a promising implant material (Spies et al. 2015a). ATZ 74	  
ceramics seem to be advantageous compared with Y-TZP regarding their susceptibility to the 75	  
tetragonal to monoclinic (tàm) phase transformation and, therefore, aging induced fatigue 76	  
(Kohorst et al. 2012; Schneider et al. 2008). 77	  
The data on the clinical application of zirconia implants is limited (Depprich et al. 2014). 78	  
Regarding the use of ATZ as implant material, only one short-term investigation is available 79	  
(Spies et al. 2015b). Therefore, the aim of the present prospective clinical investigation was to 80	  
determine the survival and success rate including the peri-implant bone loss, soft tissue 81	  
parameters, and patient-reported outcome measures of a one-piece ATZ ceramic implant after 82	  
five years. This article presents the currently available results after three years of observation.   83	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Materials and Methods 84	  
Study design 85	  
Considering the inclusion and exclusion criteria, patients were consecutively included having 86	  
signed an informed consent form. The patients had to be systemically healthy and in need of 87	  
an implant-supported single tooth or terminally attached three-unit bridge restoration. Only 88	  
one reconstruction per patient was allowed. The primary outcome was the survival and 89	  
success rate of the ceramic implant including the radiographic evaluation of peri-implant bone 90	  
loss. In addition, secondary outcomes were the clinical evaluation of the peri-implant soft-91	  
tissue and patient-reported outcome measures, respectively. The investigation was approved 92	  
by the ethics committee of the University’s Medical Center (investigation number: 337/04; 93	  
02/22/2008) and performed considering the STROBE Statement for cohort studies 94	  
(Strengthening the reporting of observational studies in epidemiology; http://www.strobe-95	  
statement.org). 96	  
Study implants and implant placement 97	  
The CE-marked implants (Ziraldent® FR1; Metoxit AG, Thayngen, Switzerland), the pre-98	  
surgical evaluations and surgical procedures as well as the peri-operative medications were 99	  
described in detail elsewhere (Spies et al. 2015b). Implants were placed in healed and fresh 100	  
extraction sites. When implant sites presented bone fenestrations or dehiscences, regenerative 101	  
procedures according to the principles of GBR using a resorbable membrane (Bio-Gide®, 102	  
Geistlich Pharma AG, Wolhusen, Switzerland) and a bovine bone substitute (Bio-Oss®, 103	  
Geistlich Pharma AG) were performed. For the immediate temporization of the implants, a 104	  
primary stability of at least 30 Ncm was mandatory. This insertion torque value was chosen 105	  
on the basis of the positive implant survival results of immediately loaded titanium implants 106	  
published by several authors (Crespi et al. 2008; Schincaglia et al. 2008; Testori et al. 2007). 107	  
Occlusal and approximal contacts were removed to avoid excessive forces on the implants. In 108	  
order to monitor the marginal bone loss at implants and neighboring teeth, an individualized 109	  
intraoral X-ray film holder was constructed after implant placement to facilitate the making of 110	  
standardized radiographs. After 7 to 10 days, sutures were removed and the surgical area 111	  
inspected for any healing problems.   112	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Prosthesis insertion 113	  
The patients wore the provisional restorations for at least six weeks in the lower jaw and for at 114	  
least 14 weeks in the upper jaw. The final prosthetic reconstructions consisted of all-ceramic 115	  
single-crowns (IPS e.max® CAD LT, Ivoclar Vivadent, Schaan, Liechtenstein) and the three-116	  
unit bridges (IPS e.max® ZirCAD & IPS e.max® ZirPress LT, Ivoclar Vivadent).  117	  
Clinical follow-ups 118	  
Follow-ups were scheduled for 1, 2, 3, 4 and 5 years after implant installation. The follow-ups 119	  
involved the soft tissue parameters probing depth (PD), clinical attachment level (CAL), 120	  
gingival recession (GR), the modified bleeding index (mBI) and modified plaque index 121	  
(mPI), the latter two according to Mombelli (1987). Teeth adjacent to the implants served as 122	  
reference and the same soft tissue parameters were collected. The parameters PD, CAL and 123	  
GR were measured to the nearest millimeter with a periodontal probe (PCP 12; Hu Friedy, 124	  
Rotterdam, Netherlands). In the presence of reference teeth, the papilla height measurement 125	  
was performed according to Jemt (1997).  126	  
Bone loss/bone remodeling 127	  
After implant placement, standardized radiographs were taken using a customized film 128	  
holder. Further radiographs were taken after final crown/bridge insertion and at the one and 129	  
three-year follow-up (Supplemental figure 1). The radiographs from the timepoint of implant 130	  
installation served as marginal bone level baseline. The differences between the marginal 131	  
bone level at baseline and the subsequent follow-ups were calculated at the implant sites and 132	  
at the neighboring teeth (Supplemental figure 2). All radiographs were independently 133	  
examined at the University of Zurich (MB). 134	  
Patient reported outcome measures (PROMs) 135	  
The patients’ appraisal of function, esthetics, sense, speech and self-esteem have been 136	  
assessed at the pre-treatment examination, at the delivery of the final prosthetic restoration, 137	  
and at the follow-up sessions applying visual analogue scales (VAS). To permit a 138	  
standardized procedure, the patients were asked to mark on a line (10 cm, no scale) the point 139	  
that corresponds most with their subjective perception. The left end point represented “poor 140	  
satisfaction” (0%), the right one “excellent satisfaction” (100%). Patients’ markings were 141	  
measured with a ruler (1 mm corresponds to 1%).  142	  
  143	  
6 	  
Implant success criteria 144	  
A successful implant showed no local or systemic allergic, toxic or other negative reactions. 145	  
Furthermore, it was not mobile and still supporting the prosthetic reconstruction. Regarding 146	  
success related to bone loss, the recommendations of the group of Östman et al. (2007) where 147	  
adopted that not more than 2 mm of bone loss during the first year was acceptable for one-148	  
piece implants that were immediately temporized. A success grade I was applied to implants 149	  
with ≤ 2 mm of bone loss after three years. A success grade II was applied to implants 150	  
showing no further pathology but a bone loss/resorption of ≤ 3 mm (Östman et al. 2007; 151	  
Sennerby et al. 2008). If one or more negative reactions towards an implant were observed 152	  
but the implant and its superstructure were still in situ in a stable condition, the implant was 153	  
rated as “surviving”. Fractures or removed implants were rated as “failure”.  154	  
Statistical analyses 155	  
For the soft- and hard-tissue evaluation, linear mixed models with random intercepts were 156	  
fitted for each patient to assess time, position (mesial tooth, implant site, distal tooth) and 157	  
treatment (SC/FDP) effects on the response variables (Bone loss; PD, CAL, GR, mBI, mPI). 158	  
In consequence of the collected data at three positions (mesial tooth, implant site, distal tooth) 159	  
per patient, the patients were considered as clusters. This clustering was performed separately 160	  
for each response variable. Furthermore, multiple pairwise comparisons between the different 161	  
positions were done. Therefore, the Tukey-Kramer method was applied to correct for the 162	  
multiple testing problem (adjustment of p-values). 163	  
For the PROMs, linear and logistic mixed models with random intercepts were fitted for each 164	  
patient to evaluate time (restoration independent) and treatment (SC/FDP) effects on the 165	  
response variables.  166	  
The calculations were performed with the statistical software STATA 13 (StataCorp LT, 167	  
College Station, TX, USA) using “xtmixed” and SAS 9.3 (SAS Institute Inc., Cary, NC, 168	  
USA). The probability level for statistical significance was set to p < 0.05.  169	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Results  170	  
Forty patients (20 women and 20 men) were included in this investigation and in total 53 171	  
ceramic ATZ Ziraldent® implants were inserted (Supplemental table 1). 51 implants were 172	  
placed in healed and two implants in fresh extraction sites. All inserted implants showed a 173	  
primary stability of at least 30 Ncm and were therefore immediately temporized. All single 174	  
implants were opposed by teeth. Furthermore, except one implant-supported single crown 175	  
distal to a single tooth replacement, all single implants were mesially and distally bordered by 176	  
teeth. The FDPs were entirely bordered by teeth (9/13 only on the mesial; 4/13 on the mesial 177	  
and distal) and opposed by solely teeth (8/13), a combination of teeth and an implant-178	  
supported single crown (1/13), partially removable dental prostheses (2/13) or a combination 179	  
of teeth and a partially removable dental prosthesis (2/13). 180	  
Status of follow-up and life table analysis 181	  
Of the 53 inserted implants, 50 were finally restored: 24 with all-ceramic single crowns and 182	  
26 with (13) terminally attached all-ceramic three-unit bridges. Three posterior single 183	  
implants failed to osseointegrate and had to be removed prior to their final prosthetic 184	  
reconstruction (i.e. 3-4 weeks after implant surgery). These three implants were considered as 185	  
failures. Since one patient died after the 1 year follow-up due to a malign tumor diagnosed 186	  
after study inclusion, 36 of the remaining 37 patients with 49 implants showed up at the three-187	  
year follow-up appointment. From the delivery of the final restoration to the three-year 188	  
follow-up, no additional implant losses were observed leading to cumulative survival rate of 189	  
94.2% after 3 years. 190	  
Peri-implant soft tissue conditions  191	  
The peri-implant soft tissue conditions over time are illustrated in Figure 1. The 192	  
corresponding data including detailed information on the statistical analyses are listed in the 193	  
appendices (Supplemental tables 2 and 3). In brief: Probing depth (p<.001), clinical 194	  
attachment level (p=.002) and bleeding index (p=.002) increased significantly over time at the 195	  
implant sites whereas the plaque index remained stable (p=.096). Furthermore, gingival 196	  
recession decreased significantly (p<.001). Compared to prosthetic delivery, papilla growth 197	  
reached statistical significance (p<.001) at the one-year and the three-year follow up, 198	  
respectively. 199	  
  200	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Marginal bone remodeling  201	  
The peri-implant bone remodeling is illustrated in Figure 2. The corresponding data including 202	  
detailed information on the statistical analyses are listed in the appendices (Supplemental 203	  
table 4). Of the 49 radiographically evaluated implants, four implants (8.2%) gained some 204	  
bone from insertion to the three-year follow-up, whereas two implants (4.1%) lost more than 205	  
2 mm of bone (Table 2). A bone loss of more than 3 mm was not found at any implant site. 206	  
According to the success criteria from Östman et al. (Östman et al. 2007; Östman et al. 2008), 207	  
95.9 % of the implants were assigned to success grade I and 100 % to success grade II at the 208	  
three-year follow-up.  209	  
In summary, an average bone loss of 0.79 mm was observed from implant insertion to the 210	  
three-year follow-up. The restoration type seemed to have a significant effect on bone 211	  
resorption after three years of observation (SCs: 0.47 mm; FDPs: 1.07 mm; p<.001; Figure 212	  
2b). After the delivery of the final restoration, the bone levels showed no statistical significant 213	  
changes over time (0.09 mm; p=.700). Gender (p=.751), location (anterior/posterior; p=.844), 214	  
jaw (p=.913), implant platform (3/4/5 mm; p=.227), implant length (9/12/14 mm; p=.128), 215	  
bone quality (1-4 according to Lekholm and Zarb (1985); p=.112), bone quantity (A-E 216	  
according to Lekholm and Zarb (1985); p=.849), grafting procedure (GBR/no grafting; 217	  
p=.542), flap design (with/without releasing incisions; p=.494) and bone anchorage (mono/bi-218	  
cortical; p=.429) had no significant influence on the marginal bone level changes over time. 219	  
Patient-reported outcome measures (PROMs) 220	  
The PROMs are illustrated in Figure 3. The corresponding data including detailed information 221	  
on the statistical analyses are listed in the appendices (Supplemental table 5). Compared to the 222	  
pre-treatment situation (33.9-85.1%), all follow-up assessments revealed significantly 223	  
improved average VAS values at the delivery of the prosthetic restorations (81-97.7%; 224	  
p<.038). Whereas the improvement of sense and self-esteem remained stable over the course 225	  
of the follow-ups (p=.128), subjective patients’ perceptions of function, esthetics and speech 226	  
still increased over time (p<.022).   227	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Discussion  228	  
Clinical parameters can only provide an objective, however, limited understanding of oral 229	  
health outcomes in dental implant therapy. Therefore, it is strongly recommended to consider 230	  
PROMs in (dental implant) research as well (McGrath et al. 2012). To date, this is the first 231	  
clinical evaluation of zirconia oral implants reporting on clinical parameters and several 232	  
PROMs. Throughout, an increased satisfaction of the participants could be observed 233	  
immediately after the treatment (i.e. the delivery of the prosthetic restorations). The ongoing 234	  
assessments at the follow-up appointments showed no reduction of the positive effect (i.e. 235	  
continuously improved VAS values) over the course of the years. Thus, from the patients’ 236	  
point of view, the presented treatment using zirconia oral implants for the replacement of 237	  
missing teeth has proved to address their needs with a lasting positive effect. 238	  
Most of the currently available evaluations of zirconia oral implants are short to mid-term 239	  
reports up to 4 years of observation (Borgonovo et al. 2015; Borgonovo et al. 2013; 240	  
Borgonovo et al. 2012; Brüll et al. 2014; Cannizzaro et al. 2010; Cionca et al. 2015; Gahlert 241	  
et al. 2015; Kohal et al. 2012; Kohal et al. 2013; Payer et al. 2013; Payer et al. 2015). These 242	  
reports include a variety of superstructures from single tooth replacements to full-arch fixed 243	  
dental prosthesis at both augmented and non-augmented sites. Furthermore, they are adopting 244	  
different success criteria (Albrektsson et al. 1986; Buser et al. 1990; Naert et al. 1992; 245	  
Östman et al. 2007; Snauwaert et al. 2000) hampering the comparability of the mentioned 246	  
studies. The importance of reporting parameters like marginal bone loss (MBL) around 247	  
implants has been shown in the investigations of Kohal et al. (Kohal et al. 2012; Kohal et al. 248	  
2013). Although, an implant survival rate of 95%/98% after one year was reported, the 249	  
implant success rate at the one-year follow-up decreased considerably when the success 250	  
criteria “bone remodeling/loss” was included. According to the success criteria described by 251	  
Östman et al. (2007),  the implant success rates were as low as 66%/60% applying grade I and 252	  
86%/72% applying grade II, respectively. Reported implant survival rates of the above 253	  
mentioned publications vary between 87% (Cannizzaro et al. 2010; Cionca et al. 2015) after 254	  
one year and 100% (Borgonovo et al. 2015; Borgonovo et al. 2013; Borgonovo et al. 2012) 255	  
after up to 4 years of observation. In the current investigation, three implants were lost prior 256	  
to the delivery of the final prosthetic restorations giving an implant survival rate of 94.2% 257	  
after three years. Therefore, the presented result is located in the range of the above-258	  
mentioned investigations. The three implants that failed to osseointegrate have been removed 259	  
within the first four weeks after implant placement. After the delivery of the prosthetic 260	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restorations, there was no further failure. The early failure can possibly be accounted to the 261	  
specific requirements of the treatment with immediately temporized one-piece implants 262	  
(Östman et al. 2007; Ottoni et al. 2005; Roccuzzo et al. 2009). Especially in the initial healing 263	  
period, the mentioned treatment is highly dependent on a good patient compliance and the 264	  
individual expertise of the clinician. The MBL reported for zirconia oral implants ranges from 265	  
0.1 mm (up to three years of observation) to 2.1 mm (up to four years of observation). Thus, 266	  
the MBL observed in the present investigation (0.79 mm after 3 years) and the absence of 267	  
further statistically significant MBL after the delivery of the prosthetic restorations are 268	  
promising. As a consequence, high success rates of 96%/100% could be calculated according 269	  
to the criteria of Östman et al. (2007). Like in the majority of the mentioned investigations, 270	  
minor GBR was performed during implant surgery (28 implant sites) if necessary. Therefore, 271	  
in some post-surgical radiographs the margin of the bone substitute could be differentiated 272	  
from the surrounding pristine bone. In those cases, the upper margin of the bone substitute 273	  
was used as initial reference for the following bone loss measurements. The statistical 274	  
analysis of the MBL measurements showed no difference between augmented and non-275	  
augmented implant sites, suggesting a good tolerance of the current implant system for GBR 276	  
during implant placement. The grafted sites in the present investigation were distributed to 277	  
implants supporting SCs and FDPs as follows: 16 of 23 (70%) implants installed for a single 278	  
tooth replacement and 12/26 (46%) implants installed to support a FDP reconstruction 279	  
received a GBR. However, the restoration type showed to have a significant influence on the 280	  
MBL in the present investigation, especially within the first months after implant surgery 281	  
until final prosthesis installation (SCs: 0.39 mm; FDPs: 1.03 mm; Figure 2b). This is in 282	  
accordance with former results of Kohal and colleagues who also observed higher MBL at 283	  
zirconia one-piece implants when immediately restored with provisional three-unit FDPs (2 284	  
mm of MBL after one year) (2013) compared with immediate provisional single implant 285	  
restorations (1.3 mm of MBL after one year) (2012) and might be owed to a higher load 286	  
during the healing period. In most cases, provisional FDP restorations were installed without 287	  
distal bordering teeth and received, therefore, less protection during mastication or against 288	  
tongue and cheek pressure even if direct static and dynamic occlusion was avoided. 289	  
Nevertheless, the MBL of implants used for FDP reconstructions in the present investigation 290	  
was still acceptable. In summary, the results of the present investigation are consistent with 291	  
the available literature regarding success and survival rates of zirconia dental implants. 292	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Immediate implant placement was not an exclusion criterion of the present investigation. 293	  
However, only 2 of 53 implants were immediately installed in extraction sockets suggesting 294	  
their omission from the study resulting in an implant population solely installed in healed 295	  
ridges. The two implants installed in extraction sockets consisted of a single tooth 296	  
replacement (a first premolar in the lower jaw) and a mesial attachment of a bridge restoration 297	  
(a second premolar in the lower jaw). The former failed to osseointegrate prior to prosthetic 298	  
delivery and was, therefore, one of the three mentioned failures. The latter is still in situ 299	  
without showing any complications or abnormalities (0.7 mm marginal bone loss at the 3y 300	  
follow-up). Omitting these two patients after their initially proper inclusion to the study 301	  
would raise the overall survival rate from 94.2% (49/52 implants) to 95.9% (47/49 implants) 302	  
and, therefore, violate the ICH guideline for Good Clinical Practice (GCP). 303	  
The restorative rehabilitation of one-piece zirconia implants has its limits. The need for 304	  
esthetics on one side and the cementation difficulty of the restoration have to be considered. 305	  
The distance of the implant shoulder to the point where the implant exits the bone is 3 mm 306	  
(height of neck) and the built-in emergence profile can hardly be altered. This in turn means 307	  
that if an implant is placed to shallow in relation to the soft tissue, the emergence profile of 308	  
the crown might look unfavorable. This does not pose any problems usually in the non-visible 309	  
posterior areas, but certainly in the esthetic zone of upper anteriors and premolars. In order to 310	  
create an esthetically pleasing emergence profile, the implant has therefore to be placed 311	  
deeper in relation of the soft tissue for developing a positive emergence profile. This in turn 312	  
may lead to the problem of cement removal after crown cementation (Linkevicius et al. 2013). 313	  
This double bind can only be overcome using two piece zirconia implants with screw-314	  
retention. Efforts are undertaken to fabricate such two-piece implants.   315	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Conclusions 316	  
Considering the survival rate and the average bone loss of 0.79 mm after three years of 317	  
observation, the investigated implant system shows promising results and can be 318	  
recommended for clinical usage. However, it remains to be seen whether the 5-year follow-up 319	  
confirms the positive three-year results. 320	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Tables 324	  
Table 1: Material properties according to the manufacturer. 325	  
Characteristics  Unit Yttria-stabilized tetragonal zirconia polycrystal (Y-TZP) 
Alumina-toughened 
zirconia (ATZ) 
Components  ZrO2/Y2O3 ZrO2/Al2O3/Y2O3 
Composition wt% 95/5 76/20/4 
Density g/cm3 6.05 5.5 
Grain size µm 0.4 0.4 
Bending strength MPa 1.000 2.000 
Compressive strength MPa 2.000 2.000 
Young’s modulus GPa 200 220 
Fracture toughness MPa√m 8 8 
 326	  
Table 2: Marginal bone remodeling after 3 years of observation. 327	  
Bone resorption [mm]  n % 
< 0 mm 4 8.2 
0 mm 2 4.1 
0.1 mm - 0.5 mm 10 20.4 
0.6 mm - 1.0 mm 19 38.8 
1.1 mm - 1.5 mm 10 20.4 
1.6 mm - 2.0 mm 2 4.1 
2.1 mm - 2.5 mm 1 2.0 
2.6 mm - 3.0 mm 1 2.0 
Ʃ 49 100 
  328	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Figure legends 329	  
Figure 1: Box plot diagrams of the soft tissue evaluations (a: Probing depth; b: Clinical 330	  
attachment level; c: Gingival recession; d: Plaque index; e: Bleeding index) sorted 331	  
by position (mesial reference teeth, implant sites, distal reference teeth) at 332	  
prosthetic delivery (0) and the follow-up appointments (1: 1 year follow-up; 3: 3 333	  
year follow-up). 334	  
Figure 2: (a) Box plot diagram of bone resorption sorted by position (mesial reference teeth, 335	  
implant sites, distal reference teeth) at prosthetic delivery (0) and the follow-up 336	  
appointments (1: 1 year follow-up; 3: 3 year follow-up).  337	  
(b) Illustration of the mean bone resorption stratified by the restoration type (Single 338	  
crowns; Fixed dental prostheses) from implant insertion to the 3-year follow-up (3). 339	  
Figure 3: Box plot diagrams of patient-reported outcome measures (Visual analogue scales 340	  
[%]; a: Function/Eating; b: Esthetic/Appearance; c: Sense; d: Speech; e: Self-341	  
esteem) sorted by restoration type (Fixed dental prostheses; Single crowns) before 342	  
treatment (Pre), at prosthetic delivery (Delivery) and the follow-up appointments 343	  
(1: 1 year follow-up; 3: 3 year follow-up).   344	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